Shree Ganesh Rem Stock Price Today (NSE: 540737)
Fundamental Score
Shree Ganesh Rem Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Shree Ganesh Rem share price today is ₹650.00, up +0.00% on NSE/BSE as of 19 June 2026. Shree Ganesh Rem (540737) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹590.23 (Cr). The 52-week high for 540737 share price is ₹665.00 and the 52-week low is ₹381.10. At a P/E ratio of 28.88x, 540737 is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 17.01% and a debt-to-equity ratio of 0.24.
Shree Ganesh Rem Share Price Chart — NSE/BSE Historical Performance
Shree Ganesh Rem share price chart: 24.69% return over the past month. 52-week high ₹665.00, 52-week low ₹381.10.
Shree Ganesh Rem — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹648.00 | ₹662.00 | ₹648.00 | ₹650.00 | 9.28K (Cr) | |
| ₹650.00 | ₹665.00 | ₹642.40 | ₹649.35 | 6.86K (Cr) | |
| ₹645.00 | ₹654.90 | ₹632.00 | ₹648.25 | 12.98K (Cr) | |
| ₹659.95 | ₹660.00 | ₹625.55 | ₹649.20 | 11.17K (Cr) | |
| ₹632.00 | ₹658.00 | ₹621.30 | ₹653.75 | 21.41K (Cr) | |
| ₹610.00 | ₹632.00 | ₹610.00 | ₹625.00 | 22.77K (Cr) | |
| ₹572.00 | ₹620.00 | ₹570.00 | ₹601.15 | 23.32K (Cr) | |
| ₹572.00 | ₹574.00 | ₹555.10 | ₹567.50 | 7.45K (Cr) | |
| ₹574.00 | ₹594.00 | ₹561.25 | ₹572.15 | 10.06K (Cr) | |
| ₹567.85 | ₹589.00 | ₹542.30 | ₹554.80 | 14.97K (Cr) |
Shree Ganesh Rem — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹648.00 | ₹662.00 | ₹648.00 | ₹650.00 | +0.31% | |
| ₹482.15 | ₹665.00 | ₹480.05 | ₹649.35 | +34.68% | |
| ₹430.00 | ₹551.00 | ₹425.00 | ₹514.65 | +19.69% | |
| ₹505.00 | ₹590.00 | ₹414.00 | ₹420.05 | -16.82% | |
| ₹419.05 | ₹548.00 | ₹412.05 | ₹512.20 | +22.23% | |
| ₹461.40 | ₹481.35 | ₹381.10 | ₹417.95 | -9.42% | |
| ₹467.45 | ₹480.20 | ₹418.00 | ₹463.20 | -0.91% | |
| ₹499.90 | ₹499.90 | ₹442.10 | ₹467.45 | -6.49% | |
| ₹513.90 | ₹535.00 | ₹478.50 | ₹496.00 | -3.48% | |
| ₹600.00 | ₹609.00 | ₹494.95 | ₹513.90 | -14.35% | |
| ₹560.50 | ₹635.95 | ₹500.00 | ₹587.15 | +4.75% | |
| ₹596.50 | ₹614.95 | ₹560.00 | ₹568.55 | -4.69% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Shree Ganesh Rem Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Shree Ganesh Rem Fundamental Analysis & Valuation Benchmarking
Educational evaluation of 540737 across key market metrics for learning purposes.
Positive Indicators
10 factors identified
Strong Return on Equity (17.01%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (19.21%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (30.50%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Consistent Growth Track Record (13.20% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (18.70% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (18.76% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.24)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (9.40x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (72.80%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
5 factors identified
Profit Decline Concern (-22.74%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-6.22%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Negative Free Cash Flow (₹-23.83 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 0.01%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Shree Ganesh Rem vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Shree Ganesh Rem with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
46.3/100 | ₹650.00₹650 | ₹590.23₹590.23 | 28.88Average 28.9 Average | 17.01%Good 17.01% Good | 19.21%Good 19.21% Good | 0.24Excellent 0.2 Excellent | 18.76%Excellent 18.76% Excellent | 13.20%Good 13.20% Good | 0.00% | |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 65.2/100 | ₹1796.50₹1797 | ₹433738.68₹433738.68 | 37.57Average 37.6 Average | 16.86%Good 16.86% Good | 20.21%Excellent 20.21% Excellent | 0.07Excellent 0.1 Excellent | 23.78%Excellent 23.78% Excellent | 9.87%Good 9.87% Good | 0.89% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 67.9/100 | ₹6553.50₹6554 | ₹170445.88₹170445.88 | 68.59Average 68.6 Average | 15.35%Good 15.35% Good | 20.44%Excellent 20.44% Excellent | 0.01Excellent 0.0 Excellent | 10.41%Good 10.41% Good | 11.65%Good 11.65% Good | 0.47% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 65.3/100 | ₹4350.40₹4350 | ₹126430.62₹126430.62 | 58.36Average 58.4 Average | 26.52%Excellent 26.52% Excellent | 27.05%Excellent 27.05% Excellent | 0.33Excellent 0.3 Excellent | 13.84%Good 13.84% Good | 7.72%Good 7.72% Good | 0.86% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 59/100 | ₹1390.30₹1390 | ₹123059.76₹123059.76 | 22.62Average 22.6 Average | 17.77%Good 17.77% Good | 22.72%Excellent 22.72% Excellent | 0.01Excellent 0.0 Excellent | 28.68%Excellent 28.68% Excellent | 9.97%Good 9.97% Good | 0.85% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 59.2/100 | ₹1290.40₹1290 | ₹105224.96₹105224.96 | 18.23Average 18.2 Average | 17.96%Good 17.96% Good | 22.69%Excellent 22.69% Excellent | 0.16Excellent 0.2 Excellent | 22.28%Excellent 22.28% Excellent | 13.26%Good 13.26% Good | 0.63% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 66.7/100 | ₹2262.90₹2263 | ₹95148.15₹95148.15 | 22.00Average 22.0 Average | 20.62%Excellent 20.62% Excellent | 21.30%Excellent 21.30% Excellent | 0.32Excellent 0.3 Excellent | 54.88%Excellent 54.88% Excellent | 8.11%Good 8.11% Good | 0.58% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 68.7/100 | ₹1091.20₹1091 | ₹94253.78₹94253.78 | 18.74Average 18.7 Average | 21.21%Excellent 21.21% Excellent | 24.31%Excellent 24.31% Excellent | 0.38Excellent 0.4 Excellent | 25.92%Excellent 25.92% Excellent | 10.27%Good 10.27% Good | 1.17% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 50.6/100 | ₹2320.20₹2320 | ₹92012.53₹92012.53 | 52.62Average 52.6 Average | 14.68%Average 14.68% Average | 15.98%Good 15.98% Good | 0.55Good 0.6 Good | 11.73%Good 11.73% Good | 15.79%Excellent 15.79% Excellent | 0.04% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 28.8/100 | ₹1433.70₹1434 | ₹70798.69₹70798.69 | 20.69Average 20.7 Average | 11.08%Average 11.08% Average | 14.18%Average 14.18% Average | 0.22Excellent 0.2 Excellent | 3.87%Average 3.87% Average | 6.55%Good 6.55% Good | 0.33% |
Alkem Laboratories LtdAlkem Laborator... ALKEM • 539523 | 59.5/100 | ₹5314.50₹5315 | ₹67075.29₹67075.29 | 28.54Average 28.5 Average | 19.39%Good 19.39% Good | 20.38%Excellent 20.38% Excellent | 0.18Excellent 0.2 Excellent | 13.93%Good 13.93% Good | 9.21%Good 9.21% Good | 0.80% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price433738.68 Cr
- Divis Laboratories Ltd share price170445.88 Cr
- Torrent Pharmaceuticals Ltd share price126430.62 Cr
- Cipla Ltd share price123059.76 Cr
- Dr Reddys Laboratories Ltd share price105224.96 Cr
Shree Ganesh Rem Quarterly Performance
Latest quarterly metrics for 540737 — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-6.22%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-22.74%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
13.20%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
18.76%
Compounded annual net profit growth over 5 years
Shree Ganesh Rem Technical Indicators
SMA 50, SMA 200, RSI and volume signals for 540737 — calculated from daily price history
Momentum is strong — price may be stretched. Watch for pullbacks.
Technical indicators are for educational purposes only. Not investment advice.
Shree Ganesh Rem Financial Statements
Annual income statement, balance sheet and cash flow for Shree Ganesh Rem (540737) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Shree Ganesh Rem
About 540737 (Shree Ganesh Rem)
Shree Ganesh Rem (540737) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pharmaceuticals sector with a current... market capitalisation of ₹590.23 (Cr). Shree Ganesh Rem has delivered a Return on Equity (ROE) of 17.01% and a ROCE of 19.21%. The debt-to-equity ratio stands at 0.24, reflecting the company's capital structure. Investors tracking 540737 share price can monitor key metrics including P/E ratio, promoter holding of 72.80%, and quarterly earnings growth.
Company Details
540737 Share Price: Frequently Asked Questions
What is the current share price of Shree Ganesh Rem?
Shree Ganesh Rem (540737) trades at ₹650.00 on BSE. Market cap ₹590.23 (Cr). Educational data only.
What is the P/E ratio of Shree Ganesh Rem?
Shree Ganesh Rem has a P/E of 28.88x vs industry average 31.77x.
What is the Bull Run score for Shree Ganesh Rem?
Shree Ganesh Rem has a Bull Run score of 46.3/100 based on 25+ financial parameters.
Does Shree Ganesh Rem pay dividends?
Shree Ganesh Rem has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Shree Ganesh Rem?
Shree Ganesh Rem has ROE of 17.01%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Shree Ganesh Rem?
Shree Ganesh Rem has debt-to-equity of 0.24.
Is Shree Ganesh Rem a good investment?
Bull Run gives Shree Ganesh Rem a score of 46.3/100. This is not investment advice — consult a SEBI-registered advisor.